Article Details
Retrieved on: 2021-03-05 10:30:00
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Five Prime's lead candidate is bemarituzumab, a monoclonal antibody designed to block tumor growth in patients with tumors that overexpress ...
Article found on: bioprocessintl.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here